Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 12;24(1):696.
doi: 10.1186/s12879-024-09593-6.

Assessing seropositivity of MMR antibodies in individuals aged 2-22: evaluating routine vaccination effectiveness after the 2003 mass campaign-a study from Iran's National Measles Laboratory

Fateme Ghafoori  1 , Talat Mokhtari-Azad  1   2 , Abbas Rahimi Foroushani  3 , Mohammad Farahmand  1   4 , Azade Shadab  1   2 , Vahid Salimi  5   6
Affiliations

Assessing seropositivity of MMR antibodies in individuals aged 2-22: evaluating routine vaccination effectiveness after the 2003 mass campaign-a study from Iran's National Measles Laboratory

Fateme Ghafoori et al. BMC Infect Dis. .

Abstract

Background and purpose: The seroprevalence of antibodies against measles, mumps, and rubella (MMR) was evaluated 17 years following a mass vaccination campaign in individuals aged 2 to 22 years who had received routine immunization but were not eligible for an extended immunization program.

Methods: Samples were acquired from Iran's National Measles Laboratory (NML), with individuals showing positive IgM results excluded. Out of the samples collected in 2020, a random selection of 290 serum samples was chosen, representing individuals between the ages of 2 and 22 years from diverse regions in the country. These samples were subjected to analysis using an enzyme-linked immunosorbent assay (ELISA) to quantify specific IgG antibodies against MMR.

Results: The seroprevalence rates of antibodies for measles, mumps, and rubella were determined to be 76.2%, 89.3%, and 76.9%, respectively. Younger age groups exhibited higher seropositivity rates for measles and mumps, whereas the 7- to 11-year-old group demonstrated the highest seropositivity rate for rubella. A reduction in antibody status was observed from younger to older age groups, particularly those aged 17-22.

Conclusion: The study unveiled suboptimal antibody levels for measles and rubella, highlighting the necessity for further investigation and potential adjustments to future vaccination strategies. Moreover, the decline in antibody status post-vaccination can accumulate in seronegative individuals over time, elevating the risk of outbreaks.

Keywords: Antibody status; Measles; Mumps; Rubella; Seroprevalence; Vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Antibody status to measles, mumps and rubella among people aged 2 to 22 who were not attended in mass campaign 2003 in 2020 in Iran
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Honarvar B, Moghadami M, Moattari A, Emami A, Odoomi N, Bagheri Lankarani K. Seroprevalence of anti-rubella and anti-measles IgG antibodies in pregnant women in Shiraz, Southern Iran: outcomes of a nationwide measles-rubella mass vaccination campaign. PLoS ONE. 2013;8(1):e55043. doi: 10.1371/journal.pone.0055043. - DOI - PMC - PubMed
    1. Zahraei SM, Izadi S, Gouya MM, Hashemi-Shahri SM, Mohammadi M. Immunization coverage of children aged 24–35 months in the Islamic Republic of Iran: a national cluster coverage survey. East Mediterr Health J. 2022;28(2):121–9. doi: 10.26719/emhj.21.059. - DOI - PubMed
    1. Zahraei SM, Izadi S, Mokhtari-Azad T. Factors affecting the seroconversion rate of 12-month-old babies after the first injection of measles vaccine in the southeast of Iran. Hum Vaccines Immunotherapeutics. 2016;12(12):3118–24. doi: 10.1080/21645515.2016.1214346. - DOI - PMC - PubMed
    1. Gonçalves G, Frade J, Nunes C, Mesquita JR, Nascimento MSJ. Persistence of measles antibodies, following changes in the recommended age for the second dose of MMR-vaccine in Portugal. Vaccine. 2015;33(39):5057–63. doi: 10.1016/j.vaccine.2015.08.057. - DOI - PubMed
    1. Kang HJ, Han YW, Kim SJ, Kim Y-J, Kim A-R, Kim JA, et al. An increasing, potentially measles-susceptible population over time after vaccination in Korea. Vaccine. 2017;35(33):4126–32. doi: 10.1016/j.vaccine.2017.06.058. - DOI - PubMed

MeSH terms

LinkOut - more resources